Your browser doesn't support javascript.
loading
Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers.
Zhong, Yali; Li, Xiaoli; Ji, Yasai; Li, Xiaoran; Li, Yaqing; Yu, Dandan; Yuan, Yuan; Liu, Jian; Li, Huixiang; Zhang, Mingzhi; Ji, Zhenyu; Fan, Dandan; Wen, Jianguo; Goscinski, Mariusz Adam; Yuan, Long; Hao, Bin; Nesland, Jahn M; Suo, Zhenhe.
Afiliación
  • Zhong Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
  • Li X; Department of Gastroenterology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
  • Ji Y; Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Montebello, Oslo, Norway.
  • Li X; Department of Pathology, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Li Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
  • Yu D; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
  • Yuan Y; Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Montebello, Oslo, Norway.
  • Liu J; Department of Pathology, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Li H; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
  • Zhang M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
  • Ji Z; Department of Pathology, Capital Medical University, Beijing, China.
  • Fan D; Institute of Health Quarantine, Chinese Academy of Inspection and Quarantine, Beijing, China.
  • Wen J; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
  • Goscinski MA; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
  • Yuan L; Henan Academy of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou.
  • Hao B; Henan Academy of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou.
  • Nesland JM; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Henan, China.
  • Suo Z; Department of Surgery, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Oncotarget ; 8(8): 13344-13356, 2017 Feb 21.
Article en En | MEDLINE | ID: mdl-28076853
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Células Madre Neoplásicas / Piruvato Deshidrogenasa (Lipoamida) Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Células Madre Neoplásicas / Piruvato Deshidrogenasa (Lipoamida) Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos